PD Dr. Jörg Distler



Organisation


Heisenberg-Professur für Molekulare Mechanismen der Organfibrose


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 17 Go to next page Go to last page

Liang, R.f., Kagwiria, R., Zehender, A., Dees, C., Bergmann, C., Ramming, A.,... Distler, J. (2019). Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2019-215066
Renoux, F., Stellato, M., Vogetseder, A., Huang, R., Subramaniam, A., Blyszczuk, P.,... Distler, O. (2019). FOSL-2 IS A REPRESSOR OF FOXP3 EXPRESSION DURING TREG DEVELOPMENT AND CONTROLS AUTOIMMUNITY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 1065-1065). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Wollin, L., Distler, J., Redente, E., Riches, D., Stowasser, S., & Schlenker-Herceg, R. (2019). FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES. In RESPIROLOGY (pp. 171-171). HOBOKEN: WILEY.
Harrach, S., Barz, V., Pap, T., Pavenstaedt, H., Schlatter, E., Edemir, B.,... Bertrand, J. (2019). Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts. Journal of Investigative Dermatology, 139(2), 439-447. https://dx.doi.org/10.1016/j.jid.2018.08.021
Elhai, M., Boubaya, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre Sancho, J.J.,... Allanore, Y. (2019). Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2018-214816
Distler, J. (2019). POTENTIAL CELLULAR AND MOLECULAR TARGETS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 32-33). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Kreuter, M., Bonella, F., Blank, N., Siegert, E., Henes, J., Worm, M.,... Hunzelmann, N. (2019). Predictors for the Development of Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) - Data from the German SSc-Network. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. Dallas, TX, US: NEW YORK: AMER THORACIC SOC.
Pachera, E., Assassi, S., Salazar, G., Frank-Bertoncelj, M., Distler, J., Kania, G., & Distler, O. (2019). PROFIBROTIC LNCRNA H19X: UNRAVELLING THE EFFECTS ON CHROMATIN REMODELING IN SYSTEMIC SCLEROSIS FIBROBLASTS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 167-168). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Wu, W., Jordan, S., Graf, N., Pena, J.D.O., Curram, J., Allanore, Y.,... Puttini, P.S. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5), 648-656. https://dx.doi.org/10.1136/annrheumdis-2018-213455
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A.B.,... Ramming, A. (2019). PU.1 controls fibroblast polarization and tissue fibrosis. Nature. https://dx.doi.org/10.1038/s41586-019-0896-x

Last updated on 2017-08-11 at 01:00